Brain Pericytes In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Brain pericytes are specialized mural cells embedded within the basement membrane of cerebral microvasculature, playing essential roles in maintaining blood-brain barrier (BBB) integrity, regulating cerebral blood flow, and supporting neuronal health. These cells have emerged as critical players in neurodegenerative diseases, with pericyte dysfunction contributing to Alzheimer's disease (AD), Parkinson's disease (PD), vascular cognitive impairment, and amyotrophic lateral sclerosis (ALS). Understanding pericyte biology provides new therapeutic avenues for addressing neurovascular dysfunction in these disorders [1].
Brain pericytes exhibit a unique distribution pattern along the cerebral microvasculature:
Capillary Networks: Pericytes are most abundant on capillaries, where they can cover up to 80-90% of the vessel surface. Each capillary segment may be associated with 1-3 pericytes.
Precapillary Arterioles: Fewer pericytes are found on precapillary arterioles, where smooth muscle cells take over perivascular coverage.
Postcapillary Venules: Pericyte coverage decreases further along the venous side of the circulation.
Spatial Organization: Pericytes are positioned at regular intervals along capillaries, with their processes extending to ensheath the vessel wall.
Brain pericytes possess distinctive morphological and molecular features:
Morphology: Small cell bodies with multiple elongated processes that wrap around capillaries. The nucleus is often prominent and displaced to one side of the cell.
Molecular Markers:
Gap Junctions: Pericytes communicate via gap junctions, allowing coordinated vasomotor responses.
Pericytes are essential for BBB development and maintenance:
Tight Junction Regulation: Pericytes secrete factors that promote tight junction formation between endothelial cells, including angiopoietin-1 and GDNF.
Endothelial Transport: They regulate the expression and polarization of endothelial transporters, controlling what substances enter the brain parenchyma.
Aβ Clearance: Pericytes express transporters (LRP1) that facilitate amyloid-beta clearance from the brain across the BBB.
Leukocyte Trafficking: Pericytes modulate immune cell entry into the CNS by regulating endothelial adhesion molecule expression.
Pericytes are the primary regulators of capillary blood flow:
Capillary Diameter Control: Pericyte contractile activity can alter capillary diameter, directly affecting cerebral blood flow.
Neurovascular Coupling: These cells respond to neuronal activity through calcium signaling, enabling blood flow to match metabolic demand.
Autoregulation: Pericytes help maintain constant blood flow despite changes in systemic blood pressure.
Functional Hyperemia: During increased neural activity, pericytes dilate capillaries to increase oxygen and glucose delivery.
During development, pericytes are crucial for vascular formation:
Vessel Stabilization: Pericytes are recruited to nascent vessels via PDGF-B signaling, stabilizing growing vasculature.
Maturation: They promote vessel maturation by secreting TGF-β and other factors that enhance endothelial barrier function.
Survival Signals: Pericyte-derived factors support endothelial cell survival and maintain vascular integrity.
Pericyte function is regulated by several key signaling pathways:
PDGF-B/PDGFRβ: The primary pathway for pericyte recruitment and survival. Endothelial cells secrete PDGF-B to attract pericyte progenitors.
TGF-β Signaling: Bidirectional communication between pericytes and endothelial cells regulates vessel stability and pericyte differentiation.
Notch Pathway: Controls pericyte coverage and arterial-venous specification.
VEGF Regulation: Pericytes modulate VEGF signaling, influencing endothelial proliferation and barrier properties.
Several transporters on pericytes regulate neurovascular function:
Pericyte dysfunction is increasingly recognized as a key contributor to AD pathogenesis:
Pericyte Loss: Post-mortem studies reveal significant pericyte loss in AD brains, particularly in regions vulnerable to amyloid deposition [2].
BBB Breakdown: Pericyte deficiency leads to BBB breakdown, allowing plasma proteins and potentially toxic substances into the brain.
Aβ Accumulation: Impaired pericyte-mediated Aβ clearance contributes to amyloid plaque formation. Pericytes from AD patients show reduced Aβ uptake and degradation.
Reduced Cerebral Blood Flow: Pericyte dysfunction contributes to hypoperfusion observed in AD, which may exacerbate cognitive decline.
Neurovascular Unit Dysfunction: Pericytes are central to the neurovascular unit; their dysfunction disrupts neuron-vessel communication [3].
Pericyte alterations in PD contribute to nigral vulnerability:
Nigral Pericyte Changes: The substantia nigra shows selective pericyte pathology in PD, with morphological abnormalities and reduced coverage.
Blood Flow Deficits: Cerebral hypoperfusion is observed in PD patients, potentially related to pericyte dysfunction.
BBB Permeability: Evidence suggests increased BBB permeability in PD, which may reflect pericyte injury.
α-Synuclein Interactions: Pericytes can take up extracellular α-synuclein, potentially contributing to its propagation and cellular stress responses.
Pericytes are central to small vessel disease:
White Matter Lesions: Pericyte dysfunction contributes to white matter injury through impaired blood flow regulation and BBB breakdown.
Small Vessel Disease: Pericyte loss and dysfunction are hallmark features of cerebral small vessel disease.
Cognitive Decline: Vascular cognitive impairment correlates with pericyte marker levels in cerebrospinal fluid.
Treatment Targets: Pericyte-protective strategies are being explored to prevent vascular cognitive decline.
Understanding pericyte biology has led to strategies for improved CNS drug delivery:
Pericyte-Targeted Nanoparticles: Engineering nanoparticles that specifically bind pericyte surface receptors enables targeted delivery.
PDGF-BB Co-administration: Administering PDGF-BB with therapeutic agents enhances pericyte coverage and drug penetration.
Receptor-Mediated Transport: Utilizing endogenous transport systems (e.g., LRP1) to cross the BBB through pericyte-mediated transcytosis.
Protecting pericytes offers neuroprotective benefits:
PDGF-BB Therapy: Recombinant PDGF-BB has shown promise in promoting pericyte survival and BBB integrity in preclinical models.
TGF-β Modulation: Enhancing TGF-β signaling can improve pericyte function and vascular stability.
VEGF Manipulation: Balancing VEGF signaling supports both angiogenesis and barrier function.
Aβ-Targeting: Clearing pericyte-bound Aβ or preventing its accumulation protects pericyte function.
The study of brain pericytes employs multiple approaches:
Brain Pericytes In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Brain Pericytes In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Pericytes regulate the blood-brain barrier - Armulik et al., Nature 2010 - Seminal paper demonstrating pericyte requirement for BBB formation.
Pericyte loss influences Alzheimer-like neurodegeneration - Sagare et al., Brain 2013 - Shows pericyte loss drives neurodegeneration in AD models.
Pericytes control key neurovascular functions - Bell et al., Neuron 2010 - Comprehensive analysis of pericyte functions in adult brain.
Neurovascular unit dysfunction in Alzheimer's disease - Review of neurovascular contributions to AD pathogenesis.
Pericyte dysfunction in Parkinson's disease - Evidence for pericyte involvement in PD vasculature.